Literature DB >> 28375519

Impact of Type I and III Interferons on Respiratory Superinfections Due to Multidrug-Resistant Pathogens.

Dane Parker1.   

Abstract

The increased morbidity and mortality associated with bacterial pneumonias that are acquired following influenza infection are well appreciated by clinicians. One of the major components of the immune response to influenza is the induction of the types I and III interferon cascades, which encompasses the activation of over 300 genes. The immunological consequences of IFN activation, while important for viral clearance, modify the host proinflammatory responses through effects on the inflammasome, Th17 signaling and recruitment of phagocytic cells. IFN signaling affects both susceptibility to subsequent Streptococcus pneumoniae and Staphylococcus aureus infection as well as the intensity of the immune responses associated with pulmonary damage. Appreciation for the effects of IFN activation on anti-bacterial pulmonary defense mechanisms should help to inform therapeutic strategies in an ICU setting.
© The Author 2017. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail journals.permissions@oup.com.

Entities:  

Keywords:  Staphylococcus aureus; Streptococcus pneumoniae; influenza; pneumonia; superinfection; type I interferon; type III interferon

Mesh:

Substances:

Year:  2017        PMID: 28375519      PMCID: PMC5853883          DOI: 10.1093/infdis/jiw466

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  91 in total

1.  IL-28, IL-29 and their class II cytokine receptor IL-28R.

Authors:  Paul Sheppard; Wayne Kindsvogel; Wenfeng Xu; Katherine Henderson; Stacy Schlutsmeyer; Theodore E Whitmore; Rolf Kuestner; Ursula Garrigues; Carl Birks; Jenny Roraback; Craig Ostrander; Dennis Dong; Jinu Shin; Scott Presnell; Brian Fox; Betty Haldeman; Emily Cooper; David Taft; Teresa Gilbert; Francis J Grant; Monica Tackett; William Krivan; Gary McKnight; Chris Clegg; Don Foster; Kevin M Klucher
Journal:  Nat Immunol       Date:  2002-12-02       Impact factor: 25.606

Review 2.  Inflammasome Complexes: Emerging Mechanisms and Effector Functions.

Authors:  Vijay A K Rathinam; Katherine A Fitzgerald
Journal:  Cell       Date:  2016-05-05       Impact factor: 41.582

3.  Halothane modulates the type i interferon response to influenza and minimizes the risk of secondary bacterial pneumonia through maintenance of neutrophil recruitment in an animal model.

Authors:  Brian A MacDonald; Krishnan V Chakravarthy; Bruce A Davidson; Barbara A Mullan; Ravi Alluri; Anders P Hakansson; Paul R Knight
Journal:  Anesthesiology       Date:  2015-09       Impact factor: 7.892

4.  Pulmonary antibacterial defenses during mild and severe influenza virus infection.

Authors:  C L Nickerson; G J Jakab
Journal:  Infect Immun       Date:  1990-09       Impact factor: 3.441

Review 5.  Nasal carriage of Staphylococcus aureus and prevention of nosocomial infections.

Authors:  J A J W Kluytmans; H F L Wertheim
Journal:  Infection       Date:  2005-02       Impact factor: 3.553

Review 6.  Regulation of type I interferon responses.

Authors:  Lionel B Ivashkiv; Laura T Donlin
Journal:  Nat Rev Immunol       Date:  2014-01       Impact factor: 53.106

7.  Modulation of inflammasome-mediated pulmonary immune activation by type I IFNs protects bone marrow homeostasis during systemic responses to Pneumocystis lung infection.

Authors:  Steve Searles; Katherine Gauss; Michelle Wilkison; Teri R Hoyt; Erin Dobrinen; Nicole Meissner
Journal:  J Immunol       Date:  2013-08-23       Impact factor: 5.422

8.  Lambda Interferon Restructures the Nasal Microbiome and Increases Susceptibility to Staphylococcus aureus Superinfection.

Authors:  Paul J Planet; Dane Parker; Taylor S Cohen; Hannah Smith; Justinne D Leon; Chanelle Ryan; Tobin J Hammer; Noah Fierer; Emily I Chen; Alice S Prince
Journal:  mBio       Date:  2016-02-09       Impact factor: 7.867

9.  Kinetics of coinfection with influenza A virus and Streptococcus pneumoniae.

Authors:  Amber M Smith; Frederick R Adler; Ruy M Ribeiro; Ryan N Gutenkunst; Julie L McAuley; Jonathan A McCullers; Alan S Perelson
Journal:  PLoS Pathog       Date:  2013-03-21       Impact factor: 6.823

10.  Bacterial pathogens activate a common inflammatory pathway through IFNλ regulation of PDCD4.

Authors:  Taylor S Cohen; Alice S Prince
Journal:  PLoS Pathog       Date:  2013-10-03       Impact factor: 6.823

View more
  6 in total

1.  Monocytes Represent One Source of Bacterial Shielding from Antibiotics following Influenza Virus Infection.

Authors:  Karl J Fischer; Vijaya Kumar Yajjala; Shruti Bansal; Christopher Bauer; Ruiling Chen; Keer Sun
Journal:  J Immunol       Date:  2019-02-11       Impact factor: 5.422

2.  Host-Pathogen Interface: Progress in Understanding the Pathogenesis of Infection Due to Multidrug-Resistant Bacteria in the Intensive Care Unit.

Authors:  Danielle Ahn; Alice Prince
Journal:  J Infect Dis       Date:  2017-02-15       Impact factor: 5.226

Review 3.  Bacterial-Host Interactions: Physiology and Pathophysiology of Respiratory Infection.

Authors:  A P Hakansson; C J Orihuela; D Bogaert
Journal:  Physiol Rev       Date:  2018-04-01       Impact factor: 37.312

Review 4.  Pathogenesis of Respiratory Viral and Fungal Coinfections.

Authors:  Fabián Salazar; Elaine Bignell; Gordon D Brown; Peter C Cook; Adilia Warris
Journal:  Clin Microbiol Rev       Date:  2021-11-17       Impact factor: 26.132

5.  Type III interferons: Balancing tissue tolerance and resistance to pathogen invasion.

Authors:  Achille Broggi; Francesca Granucci; Ivan Zanoni
Journal:  J Exp Med       Date:  2020-01-06       Impact factor: 14.307

6.  May interferon λ be a novel therapeutic approach against COVID-19?

Authors:  Azam Roohi; Pejman Soroosh
Journal:  Med Hypotheses       Date:  2020-10-22       Impact factor: 1.538

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.